Exact Mass: 246.1076

Exact Mass Matches: 246.1076

Found 193 metabolites which its exact mass value is equals to given mass value 246.1076, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Elliptisine

5,11-dimethyl-6H-pyrido(4,3-b)carbazole

C17H14N2 (246.1157)


Ellipticine is a organic heterotetracyclic compound that is pyrido[4,3-b]carbazole carrying two methyl substituents at positions 5 and 11. It has a role as an antineoplastic agent and a plant metabolite. It is an organic heterotetracyclic compound, an organonitrogen heterocyclic compound, a polycyclic heteroarene and an indole alkaloid. Ellipticine (NSC 71795) is a potent antineoplastic agent; inhibits DNA topoisomerase II activities. Ellipticine (NSC 71795) is a potent antineoplastic agent; inhibits DNA topoisomerase II activities.

   

N-Acetyltryptophan

(2S)-2-[(1-hydroxyethylidene)amino]-3-(1H-indol-3-yl)propanoic acid

C13H14N2O3 (246.1004)


N-Acetyl-L-tryptophan or N-Acetyltryptophan, belongs to the class of organic compounds known as N-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. N-Acetyltryptophan can also be classified as an alpha amino acid or a derivatized alpha amino acid. Technically, N-Acetyltryptophan is a biologically available N-terminal capped form of the proteinogenic alpha amino acid L-tryptophan. N-acetyl amino acids can be produced either via direct synthesis of specific N-acetyltransferases or via the proteolytic degradation of N-acetylated proteins by specific hydrolases. N-terminal acetylation of proteins is a widespread and highly conserved process in eukaryotes that is involved in protection and stability of proteins (PMID: 16465618). About 85\\\\\% of all human proteins and 68\\\\\% of all yeast proteins are acetylated at their N-terminus (PMID: 21750686). Several proteins from prokaryotes and archaea are also modified by N-terminal acetylation. The majority of eukaryotic N-terminal-acetylation reactions occur through N-acetyltransferase enzymes or NAT’s (PMID: 30054468). These enzymes consist of three main oligomeric complexes NatA, NatB, and NatC, which are composed of at least a unique catalytic subunit and one unique ribosomal anchor. The substrate specificities of different NAT enzymes are mainly determined by the identities of the first two N-terminal residues of the target protein. The human NatA complex co-translationally acetylates N-termini that bear a small amino acid (A, S, T, C, and occasionally V and G) (PMID: 30054468). NatA also exists in a monomeric state and can post-translationally acetylate acidic N-termini residues (D-, E-). NatB and NatC acetylate N-terminal methionine with further specificity determined by the identity of the second amino acid. N-acetylated amino acids, such as N-acetyltryptophan can be released by an N-acylpeptide hydrolase from peptides generated by proteolytic degradation (PMID: 16465618). In addition to the NAT enzymes and protein-based acetylation, N-acetylation of free tryptophan can also occur. Many N-acetylamino acids, including N-acetyltryptophan are classified as uremic toxins if present in high abundance in the serum or plasma (PMID: 26317986; PMID: 20613759). Uremic toxins are a diverse group of endogenously produced molecules that, if not properly cleared or eliminated by the kidneys, can cause kidney damage, cardiovascular disease and neurological deficits (PMID: 18287557). N-Acetyltryptophan has also been used as a protein stabilizer. It prevents protein molecules from oxidative degradation by scavenging oxygen dissolved in protein solutions (PMID: 21903216 ). N-Acetyltryptophan has been identified as a catabolite of tryptophan generated by the gut microbiota. After absorption through the intestinal epithelium, tryptophan catabolites enter the bloodstream and are later excreted in the urine (PMID: 28916042). N-Acetyltryptophan is an inhibitor of cytochrome c release and an antagonist of the neurokinin 1 receptor (NK-1R). These inhibitory effects are thought have a useful role in neuroprotection. For instance, in mouse models of amyotrophic lateral sclerosis (ALS) the administration of N-Acetyltryptophan has been shown delay disease onset, extend survival, and ameliorate deterioration in motor performance ALS transgenic mice (PMID: 25986728). N-acetyltryptophan has been shown to significantly reduce blood-brain barrier permeability and improve functional outcome in rat models of traumatic brain injury (PMID: 29256408). N-Acetyltryptophan has also been shown to have a role in preventing hepatic ischemia-reperfusion injury. This is thought to occur through de-activation of the RIP2/caspase/IL-1beta signaling pathway (PMID: 31184936). D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors Ac-DL-Trp-OH is an endogenous metabolite. Ac-DL-Trp-OH is an endogenous metabolite. N-Acetyl-L-tryptophan is an endogenous metabolite.

   

Methylphenobarbital

5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione

C13H14N2O3 (246.1004)


Methylphenobarbital is only found in individuals that have used or taken this drug. It is a barbiturate that is metabolized to phenobarbital. It has been used for similar purposes, especially in epilepsy, but there is no evidence mephobarbital offers any advantage over phenobarbital. [PubChem]Methylphenobarbital binds at a distinct binding site associated with a Cl- ionopore at the GABAA receptor, increasing the duration of time for which the Cl- ionopore is open. The post-synaptic inhibitory effect of GABA in the thalamus is, therefore, prolonged. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives N - Nervous system > N03 - Antiepileptics > N03A - Antiepileptics > N03AA - Barbiturates and derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C67084 - Barbiturate D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

   

Olivacine

6H-Pyrido[4,3-b]carbazole,1,5-dimethyl-

C17H14N2 (246.1157)


D000970 - Antineoplastic Agents > D000972 - Antineoplastic Agents, Phytogenic > D004611 - Ellipticines

   

Ellipticine

5,11-dimethyl-6H-pyrido[4,3-b]carbazole

C17H14N2 (246.1157)


Ellipticine is a organic heterotetracyclic compound that is pyrido[4,3-b]carbazole carrying two methyl substituents at positions 5 and 11. It has a role as an antineoplastic agent and a plant metabolite. It is an organic heterotetracyclic compound, an organonitrogen heterocyclic compound, a polycyclic heteroarene and an indole alkaloid. Ellipticine is a potent antineoplastic agent. Ellipticine is a natural product found in Asparagus cochinchinensis, Aspergillus sclerotiorum, and other organisms with data available. A organic heterotetracyclic compound that is pyrido[4,3-b]carbazole carrying two methyl substituents at positions 5 and 11. Ellipticine. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=519-23-3 (retrieved 2024-06-29) (CAS RN: 519-23-3). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). Ellipticine (NSC 71795) is a potent antineoplastic agent; inhibits DNA topoisomerase II activities. Ellipticine (NSC 71795) is a potent antineoplastic agent; inhibits DNA topoisomerase II activities.

   

Nigellicine

1-hydroxy-3-methyl-6H,7H,8H,9H-10λ⁵-pyridazino[1,2-a]indazol-10-ylium-11-carboxylate

C13H14N2O3 (246.1004)


Nigellicine is found in herbs and spices. Nigellicine is an alkaloid from the seeds of Nigella sativa (black cumin

   

Prolyl-Methionine

2-{[hydroxy(pyrrolidin-2-yl)methylidene]amino}-4-(methylsulphanyl)butanoic acid

C10H18N2O3S (246.1038)


Prolyl-Methionine is a dipeptide composed of proline and methionine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Methionyl-Proline

1-[2-Amino-4-(methylsulphanyl)butanoyl]pyrrolidine-2-carboxylic acid

C10H18N2O3S (246.1038)


Methionyl-Proline is a dipeptide composed of methionine and proline. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

cyclic 6-Hydroxymelatonin

1-{6-hydroxy-5-methoxy-1H,2H,3H,8H-pyrrolo[2,3-b]indol-1-yl}ethan-1-one

C13H14N2O3 (246.1004)


cyclic 6-Hydroxymelatonin is a metabolite of melatonin. Melatonin Listen/ˌmɛləˈtoʊnɪn/, also known chemically as N-acetyl-5-methoxytryptamine, is a naturally occurring compound found in animals, plants, and microbes. In animals, circulating levels of the hormone melatonin vary in a daily cycle, thereby allowing the entrainment of the circadian rhythms of several biological functions. (Wikipedia)

   

3-Phenylacetylamino-2,6-piperidinedione

N-(2,6-dioxopiperidin-3-yl)-2-phenylacetamide

C13H14N2O3 (246.1004)


   

3,3'-Diindolylmethane

3-[(1H-indol-3-yl)methyl]-1H-indole

C17H14N2 (246.1157)


C1892 - Chemopreventive Agent > C54630 - Phase II Enzymes Inducer D020011 - Protective Agents > D016588 - Anticarcinogenic Agents D000970 - Antineoplastic Agents 3,3'-Diindolylmethane is a strong, pure androgen receptor (AR) antagonist. 3,3'-Diindolylmethane is a strong, pure androgen receptor (AR) antagonist.

   

5-Ethyl-5-p-tolylbarbituric acid

5-ethyl-5-(4-methylphenyl)-1,3-diazinane-2,4,6-trione

C13H14N2O3 (246.1004)


   

indolepropionylglycine

2-[3-(1H-indol-2-yl)propanoylamino]acetic acid

C13H14N2O3 (246.1004)


   

N-Acetyl-D-tryptophan

2-[(1-hydroxyethylidene)amino]-3-(1H-indol-3-yl)propanoic acid

C13H14N2O3 (246.1004)


   

2-(1H-Indol-2-ylmethyl)-1H-indole

2-[(1H-indol-2-yl)methyl]-1H-indole

C17H14N2 (246.1157)


D020011 - Protective Agents > D016588 - Anticarcinogenic Agents D000970 - Antineoplastic Agents

   

Eccremocarpol A

Eccremocarpol A

C11H18O6 (246.1103)


   

Hyrtioerectine B

Hyrtioerectine B

C13H14N2O3 (246.1004)


   

UNII-JIG1Q7Z9UH

UNII-JIG1Q7Z9UH

C17H14N2 (246.1157)


   

(+)-Musacine A

(+)-Musacine A

C11H18O6 (246.1103)


   

2,6-Diphenylphenol

2,6-Diphenylphenol

C18H14O (246.1045)


   

ethyl 5-amino-1-benzyl-1H-1,2,3-triazole-4-carboxylate

ethyl 5-amino-1-benzyl-1H-1,2,3-triazole-4-carboxylate

C12H14N4O2 (246.1117)


   

N-(3-Indolylacetyl)-L-alanine

N-(3-Indolylacetyl)-L-alanine

C13H14N2O3 (246.1004)


   

N-(6-methoxyquinolin-8-yl)alanine

N-(6-methoxyquinolin-8-yl)alanine

C13H14N2O3 (246.1004)


   

6-hydroxy-2-piperazin-1-yl-3H-quinazolin-4-one

6-hydroxy-2-piperazin-1-yl-3H-quinazolin-4-one

C12H14N4O2 (246.1117)


   

scyphiphin C

scyphiphin C

C11H18O6 (246.1103)


   

3,3-Diindolylmethane

3,3-Diindolylmethane

C17H14N2 (246.1157)


C1892 - Chemopreventive Agent > C54630 - Phase II Enzymes Inducer D020011 - Protective Agents > D016588 - Anticarcinogenic Agents D000970 - Antineoplastic Agents 3,3'-Diindolylmethane is a strong, pure androgen receptor (AR) antagonist. 3,3'-Diindolylmethane is a strong, pure androgen receptor (AR) antagonist.

   
   

2-Phenoxybiphenyl

2-Phenoxybiphenyl

C18H14O (246.1045)


   

methyl 1-hydroxy-2,6-dimethoxy-4-oxocyclohexanacetate

methyl 1-hydroxy-2,6-dimethoxy-4-oxocyclohexanacetate

C11H18O6 (246.1103)


   

(-)-(1R,3S)-7-hydroxy-1-methyl-2,3,4,9-tetrahydro-1H-beta-carboline-3-carboxylic acid|brunnein B

(-)-(1R,3S)-7-hydroxy-1-methyl-2,3,4,9-tetrahydro-1H-beta-carboline-3-carboxylic acid|brunnein B

C13H14N2O3 (246.1004)


   

Caerulomycin G

Caerulomycin G

C13H14N2O3 (246.1004)


A pyridine alkaloid that is 2,2-bipyridine substituted at position 6 by a hydroxymethyl group and at positions 3 and 4 by methoxy groups respectively. Isolated from the marine-derived actinomycete Actinoalloteichus cyanogriseus, it exhibits antineoplastic activity.

   

cyclo-L-Pro-L-Tyr

cyclo-L-Pro-L-Tyr

C13H14N2O3 (246.1004)


   

ellipticine|SJ000287331

ellipticine|SJ000287331

C17H14N2 (246.1157)


   

hyrtioreticulin D

hyrtioreticulin D

C13H14N2O3 (246.1004)


   
   
   

2-(1H-indol-2-ylmethyl)-1H-indole

2-(1H-indol-2-ylmethyl)-1H-indole

C17H14N2 (246.1157)


D020011 - Protective Agents > D016588 - Anticarcinogenic Agents D000970 - Antineoplastic Agents

   

9-mercaptodethiobiotin

9-mercaptodethiobiotin

C10H18N2O3S (246.1038)


A member of the class of imidazolidinones that is dethiobiotin carrying a mercapto substituent at position 9. An intermediate in the biosynthesis of biotin.

   

3,3\\%27-Diindolylmethane

3,3 inverted exclamation marka-Diindolylmethane

C17H14N2 (246.1157)


3,3-diindolylmethane is a member of indoles. It has a role as an antineoplastic agent and a P450 inhibitor. Diindolylmethane has been used in trials studying the prevention and treatment of SLE, Prostate Cancer, Cervical Dysplasia, Stage I Prostate Cancer, and Stage II Prostate Cancer, among others. 3,3-Diindolylmethane is a natural product found in Arundo donax, Brassica, and other organisms with data available. Diindolylmethane is a phytonutrient and plant indole found in cruciferous vegetables including broccoli, Brussels sprouts, cabbage, cauliflower and kale, with potential anti-androgenic and antineoplastic activities. As a dimer of indole-3-carbinol, diindolylmethane (DIM) promotes beneficial estrogen metabolism in both sexes by reducing the levels of 16-hydroxy estrogen metabolites and increasing the formation of 2-hydroxy estrogen metabolites, resulting in increased antioxidant activity. Although this agent induces apoptosis in tumor cells in vitro, the exact mechanism by which DIM exhibits its antineoplastic activity in vivo is unknown. C1892 - Chemopreventive Agent > C54630 - Phase II Enzymes Inducer D020011 - Protective Agents > D016588 - Anticarcinogenic Agents D000970 - Antineoplastic Agents 3,3'-Diindolylmethane is a strong, pure androgen receptor (AR) antagonist. 3,3'-Diindolylmethane is a strong, pure androgen receptor (AR) antagonist.

   

Indole-3-acetyl-L-alanine

N-(3-Indolylacetyl)-L-alanine

C13H14N2O3 (246.1004)


Annotation level-1

   

2-acetamido-3-(1H-indol-3-yl)propanoic acid

NCGC00180645-03!2-acetamido-3-(1H-indol-3-yl)propanoic acid

C13H14N2O3 (246.1004)


   

PRI_247.1079_16.2

PRI_247.1079_16.2

C13H14N2O3 (246.1004)


CONFIDENCE Tentative identification: most likely structure (Level 3); INTERNAL_ID 1602 INTERNAL_ID 1602; CONFIDENCE Tentative identification: most likely structure (Level 3)

   

N-Acetyltryptophan

N-Acetyl-DL-tryptophan

C13H14N2O3 (246.1004)


An N-acetylamino acid that is the N-acetyl derivative of tryptophan. Ac-DL-Trp-OH is an endogenous metabolite. Ac-DL-Trp-OH is an endogenous metabolite. N-Acetyl-L-tryptophan is an endogenous metabolite.

   

Ellipticine

Ellipticine

C17H14N2 (246.1157)


Annotation level-1

   
   

N-Acetyl-D-tryptophan

(R)-2-Acetamido-3-(1H-indol-3-yl)propanoic acid

C13H14N2O3 (246.1004)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors

   

N-Acetyl-tryptophan; LC-tDDA; CE10

N-Acetyl-tryptophan; LC-tDDA; CE10

C13H14N2O3 (246.1004)


   

N-Acetyl-tryptophan; LC-tDDA; CE20

N-Acetyl-tryptophan; LC-tDDA; CE20

C13H14N2O3 (246.1004)


   

N-Acetyl-tryptophan; LC-tDDA; CE30

N-Acetyl-tryptophan; LC-tDDA; CE30

C13H14N2O3 (246.1004)


   

N-Acetyl-tryptophan; LC-tDDA; CE40

N-Acetyl-tryptophan; LC-tDDA; CE40

C13H14N2O3 (246.1004)


   

N-Acetyl-tryptophan; AIF; CE0; CorrDec

N-Acetyl-tryptophan; AIF; CE0; CorrDec

C13H14N2O3 (246.1004)


   

N-Acetyl-tryptophan; AIF; CE10; CorrDec

N-Acetyl-tryptophan; AIF; CE10; CorrDec

C13H14N2O3 (246.1004)


   

N-Acetyl-tryptophan; AIF; CE30; CorrDec

N-Acetyl-tryptophan; AIF; CE30; CorrDec

C13H14N2O3 (246.1004)


   

N-Acetyl-tryptophan; AIF; CE0; MS2Dec

N-Acetyl-tryptophan; AIF; CE0; MS2Dec

C13H14N2O3 (246.1004)


   

N-Acetyl-tryptophan; AIF; CE10; MS2Dec

N-Acetyl-tryptophan; AIF; CE10; MS2Dec

C13H14N2O3 (246.1004)


   

N-Acetyl-tryptophan; AIF; CE30; MS2Dec

N-Acetyl-tryptophan; AIF; CE30; MS2Dec

C13H14N2O3 (246.1004)


   

N-(3-INDOLYLACETYL)-ALANINE

N-(3-INDOLYLACETYL)-ALANINE

C13H14N2O3 (246.1004)


   

N-acetyltryptophan_major

N-acetyltryptophan_major

C13H14N2O3 (246.1004)


   
   
   

N-Acetyl-DL-tryptophan

N-Acetyl-DL-tryptophan

C13H14N2O3 (246.1004)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors Ac-DL-Trp-OH is an endogenous metabolite. Ac-DL-Trp-OH is an endogenous metabolite.

   

Ac-Try

(2S)-2-Acetamido-3-(1H-indol-3-yl)propanoic acid

C13H14N2O3 (246.1004)


N-Acetyl-L-tryptophan is an endogenous metabolite.

   

Met-pro

4-(methylsulfanyl)-2-(pyrrolidin-2-ylformamido)butanoic acid

C10H18N2O3S (246.1038)


A dipeptide formed from L-methionine and L-proline residues.

   

Pro-met

1-[2-amino-4-(methylsulfanyl)butanoyl]pyrrolidine-2-carboxylic acid

C10H18N2O3S (246.1038)


   

Nigellicine

9-hydroxy-7-methyl-1H,2H,3H,4H-5000000,11000000$l^{5}-pyridazino[1,2-a]indazol-11-ylium-10-carboxylate

C13H14N2O3 (246.1004)


   

H-Pro-Met-OH

L-Prolyl-L-methionine

C10H18N2O3S (246.1038)


   

4-benzyloxycarbonyl-1-methyl-3,4-dihydropyrazin-2(1H)-one

4-benzyloxycarbonyl-1-methyl-3,4-dihydropyrazin-2(1H)-one

C13H14N2O3 (246.1004)


   

tert-butyl 3-formyl-1H-pyrrolo[2,3-b]pyridine-1-carboxylate

tert-butyl 3-formyl-1H-pyrrolo[2,3-b]pyridine-1-carboxylate

C13H14N2O3 (246.1004)


   

CHEMBRDG-BB 9070970

CHEMBRDG-BB 9070970

C13H14N2O3 (246.1004)


   

3-amino-4-(4-morpholino)benzotrifluoride

3-amino-4-(4-morpholino)benzotrifluoride

C11H13F3N2O (246.098)


   

N-(1-cyanocyclohexyl)-3-fluorobenzamide

N-(1-cyanocyclohexyl)-3-fluorobenzamide

C14H15FN2O (246.1168)


   

tert-Butyl 3-formyl-1H-pyrrolo[3,2-c]pyridine-1-carboxylate

tert-Butyl 3-formyl-1H-pyrrolo[3,2-c]pyridine-1-carboxylate

C13H14N2O3 (246.1004)


   

N-(1-cyanocyclohexyl)-2-fluorobenzamide

N-(1-cyanocyclohexyl)-2-fluorobenzamide

C14H15FN2O (246.1168)


   

1,1,2-Ethanetricarboxylic Acid, 2-(1,1-Dimethylethyl)1,1-Dimethyl Ester

1,1,2-Ethanetricarboxylic Acid, 2-(1,1-Dimethylethyl)1,1-Dimethyl Ester

C11H18O6 (246.1103)


   

METHYL 3-METHOXY-4-(4-METHYL-1-IMIDAZOLYL)BENZOATE

METHYL 3-METHOXY-4-(4-METHYL-1-IMIDAZOLYL)BENZOATE

C13H14N2O3 (246.1004)


   

6-METHOXY-1 2 3 4-TETRAHYDRO-9H-PYRIDO-&

6-Methoxy-1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole-1-carboxylic acid

C13H14N2O3 (246.1004)


   

1-(4-TRIFLUOROMETHOXYPHENYL)PIPERAZINE

1-(4-TRIFLUOROMETHOXYPHENYL)PIPERAZINE

C11H13F3N2O (246.098)


   

ethyl 3-(2-methoxyphenyl)-1H-pyrazole-5-carboxylate

ethyl 3-(2-methoxyphenyl)-1H-pyrazole-5-carboxylate

C13H14N2O3 (246.1004)


   

tert-Butyl 3-formyl-1H-indazole-1-carboxylate

tert-Butyl 3-formyl-1H-indazole-1-carboxylate

C13H14N2O3 (246.1004)


   

thymidine-a,a,a,6-d4

thymidine-a,a,a,6-d4

C10H10D4N2O5 (246.1154)


   

5-BENZYLOXYMETHYL-6-METHYLURACIL

5-BENZYLOXYMETHYL-6-METHYLURACIL

C13H14N2O3 (246.1004)


   

4-o-acetyl-2,5-anhydro-1,3-isopropylidene-d-glucitol

4-o-acetyl-2,5-anhydro-1,3-isopropylidene-d-glucitol

C11H18O6 (246.1103)


   

3,4-Dihydro-1(2H)-tetraphenone

3,4-Dihydro-1(2H)-tetraphenone

C18H14O (246.1045)


   

1,1-Biphenyl,4-phenoxy-

1,1-Biphenyl,4-phenoxy-

C18H14O (246.1045)


   

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[c][1,2,5]oxadiazole

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[c][1,2,5]oxadiazole

C12H15BN2O3 (246.1176)


   

6-Amino-1-benzyl-5-methylaminouracil

6-Amino-1-benzyl-5-methylaminouracil

C12H14N4O2 (246.1117)


   

2-(1H-Indol-3-ylmethyl)-1H-indole

2-(1H-Indol-3-ylmethyl)-1H-indole

C17H14N2 (246.1157)


   

potassium,[(E)-dec-1-enyl]-trifluoroboranuide

potassium,[(E)-dec-1-enyl]-trifluoroboranuide

C10H19BF3K (246.1169)


   

3-(4-METHOXYPHENYL)-1H-PYRAZOLE-5-CARBOXYLIC ACID ETHYL ESTER

3-(4-METHOXYPHENYL)-1H-PYRAZOLE-5-CARBOXYLIC ACID ETHYL ESTER

C13H14N2O3 (246.1004)


   

4-(3-P-TOLYL-[1,2,4]OXADIAZOL-5-YL)-BUTYRIC ACID

4-(3-P-TOLYL-[1,2,4]OXADIAZOL-5-YL)-BUTYRIC ACID

C13H14N2O3 (246.1004)


   

2-(MORPHOLIN-2-YLMETHYL)ISOINDOLINE-1,3-DIONE

2-(MORPHOLIN-2-YLMETHYL)ISOINDOLINE-1,3-DIONE

C13H14N2O3 (246.1004)


   

4-[CYCLOHEXYL(METHYL)AMINO]-1-BUTANOL

4-[CYCLOHEXYL(METHYL)AMINO]-1-BUTANOL

C11H13F3N2O (246.098)


   

Triethyl 1,1,2-ethanetricarboxylate

Triethyl 1,1,2-ethanetricarboxylate

C11H18O6 (246.1103)


   

1-(1-Borono-1-phenylmethyl)-1H-pyrazole-4-boronic acid

1-(1-Borono-1-phenylmethyl)-1H-pyrazole-4-boronic acid

C10H12B2N2O4 (246.0983)


   

(4R)-N-ACETYL)-4-BENZYL-2-OXAZOLIDINONE,99

(4R,5R)-Diethyl 2,2-dimethyl-1,3-dioxolane-4,5-dicarboxylate

C11H18O6 (246.1103)


   

2-Amino-3,5-diphenylpyridine

2-Amino-3,5-diphenylpyridine

C17H14N2 (246.1157)


   

BENZO[B]THIOPHEN-2-YL(CYCLOHEXYL)METHANOL

BENZO[B]THIOPHEN-2-YL(CYCLOHEXYL)METHANOL

C15H18OS (246.1078)


   

ETHYL 3-METHYL-5-OXO-1-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-4-CARBOXYLATE

ETHYL 3-METHYL-5-OXO-1-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-4-CARBOXYLATE

C13H14N2O3 (246.1004)


   

2-(4-Methylpiperazin-1-yl)-5-nitrobenzonitrile

2-(4-Methylpiperazin-1-yl)-5-nitrobenzonitrile

C12H14N4O2 (246.1117)


   

5-[2-(4-methoxyphenyl)ethyl]-1H-pyrazole-3-carboxylic acid

5-[2-(4-methoxyphenyl)ethyl]-1H-pyrazole-3-carboxylic acid

C13H14N2O3 (246.1004)


   

1,3-DIHYDRO-5-NITRO-3-SPIROCYCLOHEXANEINDOL-2-ONE

1,3-DIHYDRO-5-NITRO-3-SPIROCYCLOHEXANEINDOL-2-ONE

C13H14N2O3 (246.1004)


   

N-BOC-3-(4-Cyanophenyl)oxaziridine

N-BOC-3-(4-Cyanophenyl)oxaziridine

C13H14N2O3 (246.1004)


   

4,5-diacetyloxypentyl acetate

4,5-diacetyloxypentyl acetate

C11H18O6 (246.1103)


   

1-(4-METHOXY-PHENYL)-5-METHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID HYDRAZIDE

1-(4-METHOXY-PHENYL)-5-METHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID HYDRAZIDE

C12H14N4O2 (246.1117)


   

1-N-BOC-5-FORMYL-INDAZOLE

1-N-BOC-5-FORMYL-INDAZOLE

C13H14N2O3 (246.1004)


   

TRANS-1-(BROMOETHYL)-4-PENTYLCYCLOHEXANE

TRANS-1-(BROMOETHYL)-4-PENTYLCYCLOHEXANE

C12H23Br (246.0983)


   

tert-Butyl 1,3-dioxoisoindolin-2-ylcarbamate

tert-Butyl 1,3-dioxoisoindolin-2-ylcarbamate

C13H14N2O3 (246.1004)


   

1H-INDAZOLE-1-CARBOXYLIC ACID,6-FORMYL-,1,1-DIMETHYLETHYL ESTER

1H-INDAZOLE-1-CARBOXYLIC ACID,6-FORMYL-,1,1-DIMETHYLETHYL ESTER

C13H14N2O3 (246.1004)


   

1-PHENYL-4,5-DIHYDRO-1H-BENZO[G]INDAZOLE

1-PHENYL-4,5-DIHYDRO-1H-BENZO[G]INDAZOLE

C17H14N2 (246.1157)


   
   

6-amino-5-(benzylamino)-1-methylpyrimidine-2,4-dione

6-amino-5-(benzylamino)-1-methylpyrimidine-2,4-dione

C12H14N4O2 (246.1117)


   

6-Carboxy-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole, 2-(6-Carboxy-1H-indazol-1-yl)tetrahydro-2H-pyran

6-Carboxy-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole, 2-(6-Carboxy-1H-indazol-1-yl)tetrahydro-2H-pyran

C13H14N2O3 (246.1004)


   

N-ETHOXYCARBONYLMETHYL-6-METHOXYQUINOLINIUM BROMIDE

N-ETHOXYCARBONYLMETHYL-6-METHOXYQUINOLINIUM BROMIDE

C14H16NO3+ (246.113)


   

2-PHENYL-4,5-DIHYDRO-2H-BENZO[G]INDAZOLE

2-PHENYL-4,5-DIHYDRO-2H-BENZO[G]INDAZOLE

C17H14N2 (246.1157)


   

1-(TETRAHYDRO-2H-PYRAN-2-YL)-1H-INDAZOLE-5-CARBOXYLIC ACID

1-(TETRAHYDRO-2H-PYRAN-2-YL)-1H-INDAZOLE-5-CARBOXYLIC ACID

C13H14N2O3 (246.1004)


   

1-[4-(trifluoromethyl)pyrimidin-2-yl]-1,4-diazepane

1-[4-(trifluoromethyl)pyrimidin-2-yl]-1,4-diazepane

C10H13F3N4 (246.1092)


   

trimethyl pentane-1,3,5-tricarboxylate

trimethyl pentane-1,3,5-tricarboxylate

C11H18O6 (246.1103)


   

N-phenyl-4-(pyridin-3-yl)aniline

N-phenyl-4-(pyridin-3-yl)aniline

C17H14N2 (246.1157)


   

Methyl 4-(5-Isopropyl-1,2,4-oxadiazol-3-yl)benzoate

Methyl 4-(5-Isopropyl-1,2,4-oxadiazol-3-yl)benzoate

C13H14N2O3 (246.1004)


   

1H-1,2,3-Triazole-4-carboxylicacid, 5-amino-1-(phenylmethyl)-, ethyl ester

1H-1,2,3-Triazole-4-carboxylicacid, 5-amino-1-(phenylmethyl)-, ethyl ester

C12H14N4O2 (246.1117)


   

1-(piperidine-4-carbonyl)piperidin-4-one hydrochloride

1-(piperidine-4-carbonyl)piperidin-4-one hydrochloride

C11H19ClN2O2 (246.1135)


   

ethyl 3-(2-trimethylsilylethynyl)benzoate

ethyl 3-(2-trimethylsilylethynyl)benzoate

C14H18O2Si (246.1076)


   

4-Carboxy-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole, 2-(4-Carboxy-1H-indazol-1-yl)tetrahydro-2H-pyran

4-Carboxy-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole, 2-(4-Carboxy-1H-indazol-1-yl)tetrahydro-2H-pyran

C13H14N2O3 (246.1004)


   

1-Bromocyclododecane

1-Bromocyclododecane

C12H23Br (246.0983)


   

4-(2-ethylbenzimidazol-1-yl)-4-oxobutanoic acid

4-(2-ethylbenzimidazol-1-yl)-4-oxobutanoic acid

C13H14N2O3 (246.1004)


   

4-MORPHOLINO-3-(TRIFLUOROMETHYL)ANILINE

4-MORPHOLINO-3-(TRIFLUOROMETHYL)ANILINE

C11H13F3N2O (246.098)


   
   

3-(3-Ethyl-4-oxo-3,4-dihydro-phthalazin-1-yl)-propionic acid

3-(3-Ethyl-4-oxo-3,4-dihydro-phthalazin-1-yl)-propionic acid

C13H14N2O3 (246.1004)


   

2-methyl-4-piperazin-1-yl-6-(trifluoromethyl)pyrimidine(SALTDATA: FREE)

2-methyl-4-piperazin-1-yl-6-(trifluoromethyl)pyrimidine(SALTDATA: FREE)

C10H13F3N4 (246.1092)


   

5-(1-Piperazinyl)-1-benzofuran-2-carboxylic acid

5-(1-Piperazinyl)-1-benzofuran-2-carboxylic acid

C13H14N2O3 (246.1004)


   

Ethyl 3-(5-ethyl-1,2,4-oxadiazol-3-yl)benzoate

Ethyl 3-(5-ethyl-1,2,4-oxadiazol-3-yl)benzoate

C13H14N2O3 (246.1004)


   

Antineoplaston A10

Antineoplaston A10

C13H14N2O3 (246.1004)


C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer Antineoplaston A10, a naturally occurring substance in human body, is a Ras inhibitor potentially for the treatment of glioma, lymphoma, astrocytoma and breast cancer[1]. Antineoplaston A10, a naturally occurring substance in human body, is a Ras inhibitor potentially for the treatment of glioma, lymphoma, astrocytoma and breast cancer[1].

   

3-(4-ethoxyphenyl)-1H-pyrazole-5-carbohydrazide

3-(4-ethoxyphenyl)-1H-pyrazole-5-carbohydrazide

C12H14N4O2 (246.1117)


   

Ethyl 2-(3-oxo-3,4-dihydroquinoxalin-2-yl)propanoate

Ethyl 2-(3-oxo-3,4-dihydroquinoxalin-2-yl)propanoate

C13H14N2O3 (246.1004)


   

4-Hydroxy-1-(4-methylphenyl)-3-pyrazolecarboxylic acid ethyl ester

4-Hydroxy-1-(4-methylphenyl)-3-pyrazolecarboxylic acid ethyl ester

C13H14N2O3 (246.1004)


   

2-[3-(1H-indol-3-yl)propanoylamino]acetic Acid

2-[3-(1H-indol-3-yl)propanoylamino]acetic Acid

C13H14N2O3 (246.1004)


   

Ethyl 6,8-dimethyl-4-oxopyrido[1,2-a]pyrimidine-3-carboxylate

Ethyl 6,8-dimethyl-4-oxopyrido[1,2-a]pyrimidine-3-carboxylate

C13H14N2O3 (246.1004)


   

4H-Pyrido[1,2-a]pyrimidine-3-acetic acid, 6-methyl-4-oxo-, ethyl ester

4H-Pyrido[1,2-a]pyrimidine-3-acetic acid, 6-methyl-4-oxo-, ethyl ester

C13H14N2O3 (246.1004)


   

4H-Pyrido[1,2-a]pyrimidine-3-propanoic acid, 4-oxo-, ethyl ester

4H-Pyrido[1,2-a]pyrimidine-3-propanoic acid, 4-oxo-, ethyl ester

C13H14N2O3 (246.1004)


   

4H-Pyrido[1,2-a]pyrimidine-3-acetic acid, 9-methyl-4-oxo-, ethyl ester

4H-Pyrido[1,2-a]pyrimidine-3-acetic acid, 9-methyl-4-oxo-, ethyl ester

C13H14N2O3 (246.1004)


   

4H-Pyrido[1,2-a]pyrimidine-3-acetic acid, 7-methyl-4-oxo-, ethyl ester

4H-Pyrido[1,2-a]pyrimidine-3-acetic acid, 7-methyl-4-oxo-, ethyl ester

C13H14N2O3 (246.1004)


   

4H-Pyrido[1,2-a]pyrimidine-3-acetic acid, 8-methyl-4-oxo-, ethyl ester

4H-Pyrido[1,2-a]pyrimidine-3-acetic acid, 8-methyl-4-oxo-, ethyl ester

C13H14N2O3 (246.1004)


   

7-Methoxy-2,3-dimethyl-6-(2-nitrovinyl)indole

7-Methoxy-2,3-dimethyl-6-(2-nitrovinyl)indole

C13H14N2O3 (246.1004)


   

Elliptisine

5-23-09-00417 (Beilstein Handbook Reference)

C17H14N2 (246.1157)


D000970 - Antineoplastic Agents > D000972 - Antineoplastic Agents, Phytogenic > D004611 - Ellipticines D004791 - Enzyme Inhibitors > D014475 - Uncoupling Agents Ellipticine (NSC 71795) is a potent antineoplastic agent; inhibits DNA topoisomerase II activities. Ellipticine (NSC 71795) is a potent antineoplastic agent; inhibits DNA topoisomerase II activities.

   

N-(1H-indol-3-ylacetyl)alanine

N-(1H-indol-3-ylacetyl)alanine

C13H14N2O3 (246.1004)


   

6-[2-Oxo-5-(sulfanylmethyl)imidazolidin-4-yl]hexanoic acid

6-[2-Oxo-5-(sulfanylmethyl)imidazolidin-4-yl]hexanoic acid

C10H18N2O3S (246.1038)


   

IAA-L-Ala

N-(3-Indolylacetyl)-L-alanine

C13H14N2O3 (246.1004)


   

L-methionyl-L-proline dipeptide

L-methionyl-L-proline dipeptide

C10H18N2O3S (246.1038)


   

N-[2-(3-methylphenoxy)ethyl]-1H-1,2,4-triazole-5-carboxamide

N-[2-(3-methylphenoxy)ethyl]-1H-1,2,4-triazole-5-carboxamide

C12H14N4O2 (246.1117)


   

5-Amino-4-oxo-1,2,4,5,6,7-hexahydro-azepino[3,2,1-HI]indole-2-carboxylic acid

5-Amino-4-oxo-1,2,4,5,6,7-hexahydro-azepino[3,2,1-HI]indole-2-carboxylic acid

C13H14N2O3 (246.1004)


   

2-(4-ethylphenoxy)-N-(1H-1,2,4-triazol-5-yl)acetamide

2-(4-ethylphenoxy)-N-(1H-1,2,4-triazol-5-yl)acetamide

C12H14N4O2 (246.1117)


   

1-[5-Amino-3-(4-methoxyphenyl)-1,2,4-triazol-1-yl]-1-propanone

1-[5-Amino-3-(4-methoxyphenyl)-1,2,4-triazol-1-yl]-1-propanone

C12H14N4O2 (246.1117)


   

1-(3,4-Dihydroxyphenyl)-2-(2-ethyl-1-imidazolyl)ethanone

1-(3,4-Dihydroxyphenyl)-2-(2-ethyl-1-imidazolyl)ethanone

C13H14N2O3 (246.1004)


   

2-(3,5-dimethyl-1H-pyrazol-4-yl)-5-methoxybenzoic acid

2-(3,5-dimethyl-1H-pyrazol-4-yl)-5-methoxybenzoic acid

C13H14N2O3 (246.1004)


   

Mephobarbital

Mephobarbital

C13H14N2O3 (246.1004)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives N - Nervous system > N03 - Antiepileptics > N03A - Antiepileptics > N03AA - Barbiturates and derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C67084 - Barbiturate D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

   

Acetyl-L-tryptophan

N-Acetyl-L-tryptophan

C13H14N2O3 (246.1004)


A N-acetyl-L-amino acid that is the N-acetyl derivative of L-tryptophan. D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors N-Acetyl-L-tryptophan is an endogenous metabolite.

   

N-(indole-3-acetyl)-L-alanine

N-(indole-3-acetyl)-L-alanine

C13H14N2O3 (246.1004)


An N-acyl-L-amino acid that is the N-indole-3-acetyl derivative of L-alanine.

   

cyclic 6-Hydroxymelatonin

cyclic 6-Hydroxymelatonin

C13H14N2O3 (246.1004)


   
   

6-amino-5-(methylamino)-1-(phenylmethyl)pyrimidine-2,4-dione

6-amino-5-(methylamino)-1-(phenylmethyl)pyrimidine-2,4-dione

C12H14N4O2 (246.1117)


   

N-Acetyl-tryptophan

N-Acetyl-tryptophan

C13H14N2O3 (246.1004)


   

N-(indole-3-acetyl)-alanine

N-(indole-3-acetyl)-alanine

C13H14N2O3 (246.1004)


   

8-hydroxy-13-methoxy-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),8,10,12-tetraen-2-one

8-hydroxy-13-methoxy-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),8,10,12-tetraen-2-one

C13H14N2O3 (246.1004)


   

(1s,3s)-6-hydroxy-1-methyl-1h,2h,3h,4h,9h-pyrido[3,4-b]indole-3-carboxylic acid

(1s,3s)-6-hydroxy-1-methyl-1h,2h,3h,4h,9h-pyrido[3,4-b]indole-3-carboxylic acid

C13H14N2O3 (246.1004)


   

(1s,2s,4s,5s,6r,8s,10s)-2-(hydroxymethyl)-8,10-dimethoxy-3,9-dioxatricyclo[4.4.0.0²,⁴]decan-5-ol

(1s,2s,4s,5s,6r,8s,10s)-2-(hydroxymethyl)-8,10-dimethoxy-3,9-dioxatricyclo[4.4.0.0²,⁴]decan-5-ol

C11H18O6 (246.1103)


   

(3z,6z)-3-(3h-imidazol-4-ylmethylidene)-6-(2-methylpropylidene)pyrazine-2,5-diol

(3z,6z)-3-(3h-imidazol-4-ylmethylidene)-6-(2-methylpropylidene)pyrazine-2,5-diol

C12H14N4O2 (246.1117)


   

1-hydroxy-3-(4-hydroxyphenyl)-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one

1-hydroxy-3-(4-hydroxyphenyl)-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one

C13H14N2O3 (246.1004)


   

(3s,8as)-1-hydroxy-3-(4-hydroxyphenyl)-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one

(3s,8as)-1-hydroxy-3-(4-hydroxyphenyl)-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one

C13H14N2O3 (246.1004)


   

5-hydroxy-3-(1h-imidazol-4-ylmethylidene)-6-(2-methylpropylidene)-1h-pyrazin-2-one

5-hydroxy-3-(1h-imidazol-4-ylmethylidene)-6-(2-methylpropylidene)-1h-pyrazin-2-one

C12H14N4O2 (246.1117)


   

methyl 2-(1-hydroxy-2,6-dimethoxy-4-oxocyclohexyl)acetate

methyl 2-(1-hydroxy-2,6-dimethoxy-4-oxocyclohexyl)acetate

C11H18O6 (246.1103)


   

(1r,3r)-6-hydroxy-1-methyl-1h,2h,3h,4h,9h-pyrido[3,4-b]indole-3-carboxylic acid

(1r,3r)-6-hydroxy-1-methyl-1h,2h,3h,4h,9h-pyrido[3,4-b]indole-3-carboxylic acid

C13H14N2O3 (246.1004)


   

2,3-dihydroxypropyl 4,5-dihydroxyocta-2,6-dienoate

2,3-dihydroxypropyl 4,5-dihydroxyocta-2,6-dienoate

C11H18O6 (246.1103)


   

4-[4-(2-cyanoethoxy)phenyl]-3,4-dihydroxybutanenitrile

4-[4-(2-cyanoethoxy)phenyl]-3,4-dihydroxybutanenitrile

C13H14N2O3 (246.1004)


   

(2s)-2,3-dihydroxypropyl (2e,4s,5r,6e)-4,5-dihydroxyocta-2,6-dienoate

(2s)-2,3-dihydroxypropyl (2e,4s,5r,6e)-4,5-dihydroxyocta-2,6-dienoate

C11H18O6 (246.1103)


   

(3r,4r)-4-[4-(2-cyanoethoxy)phenyl]-3,4-dihydroxybutanenitrile

(3r,4r)-4-[4-(2-cyanoethoxy)phenyl]-3,4-dihydroxybutanenitrile

C13H14N2O3 (246.1004)


   

(1s,2r,5s,6s)-2,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-3-en-1-yl 2-methylpropanoate

(1s,2r,5s,6s)-2,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-3-en-1-yl 2-methylpropanoate

C11H18O6 (246.1103)


   

methyl 2-[(2r,6r)-1-hydroxy-2,6-dimethoxy-4-oxocyclohexyl]acetate

methyl 2-[(2r,6r)-1-hydroxy-2,6-dimethoxy-4-oxocyclohexyl]acetate

C11H18O6 (246.1103)


   

methyl (1r,4r,4as,5r,7s,7as)-1,5,7-trihydroxy-7-methyl-hexahydro-1h-cyclopenta[c]pyran-4-carboxylate

methyl (1r,4r,4as,5r,7s,7as)-1,5,7-trihydroxy-7-methyl-hexahydro-1h-cyclopenta[c]pyran-4-carboxylate

C11H18O6 (246.1103)


   

methyl 1,5,7-trihydroxy-7-methyl-hexahydro-1h-cyclopenta[c]pyran-4-carboxylate

methyl 1,5,7-trihydroxy-7-methyl-hexahydro-1h-cyclopenta[c]pyran-4-carboxylate

C11H18O6 (246.1103)


   

2-(hydroxymethyl)-8,10-dimethoxy-3,9-dioxatricyclo[4.4.0.0²,⁴]decan-5-ol

2-(hydroxymethyl)-8,10-dimethoxy-3,9-dioxatricyclo[4.4.0.0²,⁴]decan-5-ol

C11H18O6 (246.1103)


   

3-methyl-1-oxo-6h,7h,8h,9h-pyridazino[1,2-a]indazole-11-carboxylic acid

3-methyl-1-oxo-6h,7h,8h,9h-pyridazino[1,2-a]indazole-11-carboxylic acid

C13H14N2O3 (246.1004)


   

2,3-dihydroxypropyl (2e,6e)-4,5-dihydroxyocta-2,6-dienoate

2,3-dihydroxypropyl (2e,6e)-4,5-dihydroxyocta-2,6-dienoate

C11H18O6 (246.1103)


   

6-hydroxy-1-methyl-1h,2h,3h,4h,9h-pyrido[3,4-b]indole-3-carboxylic acid

6-hydroxy-1-methyl-1h,2h,3h,4h,9h-pyrido[3,4-b]indole-3-carboxylic acid

C13H14N2O3 (246.1004)


   

2,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-3-en-1-yl 2-methylpropanoate

2,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-3-en-1-yl 2-methylpropanoate

C11H18O6 (246.1103)


   

4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl 2-methylpropanoate

4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl 2-methylpropanoate

C11H18O6 (246.1103)


   

(7s)-8-hydroxy-13-methoxy-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),8,10,12-tetraen-2-one

(7s)-8-hydroxy-13-methoxy-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),8,10,12-tetraen-2-one

C13H14N2O3 (246.1004)


   

1,5-dimethyl-2h-pyrido[4,3-b]carbazole

1,5-dimethyl-2h-pyrido[4,3-b]carbazole

C17H14N2 (246.1157)


   

flavopereirine

flavopereirine

C17H14N2 (246.1157)


   

(1r,3s)-7-hydroxy-1-methyl-1h,2h,3h,4h,9h-pyrido[3,4-b]indole-3-carboxylic acid

(1r,3s)-7-hydroxy-1-methyl-1h,2h,3h,4h,9h-pyrido[3,4-b]indole-3-carboxylic acid

C13H14N2O3 (246.1004)


   

(1s,4r,5s,6r)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl 2-methylpropanoate

(1s,4r,5s,6r)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl 2-methylpropanoate

C11H18O6 (246.1103)


   

7-hydroxy-1-methyl-1h,2h,3h,4h,9h-pyrido[3,4-b]indole-3-carboxylic acid

7-hydroxy-1-methyl-1h,2h,3h,4h,9h-pyrido[3,4-b]indole-3-carboxylic acid

C13H14N2O3 (246.1004)


   

(2r)-2,3-dihydroxypropyl (2e,4s,5s,6e)-4,5-dihydroxyocta-2,6-dienoate

(2r)-2,3-dihydroxypropyl (2e,4s,5s,6e)-4,5-dihydroxyocta-2,6-dienoate

C11H18O6 (246.1103)


   

(8s,10s)-2-(hydroxymethyl)-8,10-dimethoxy-3,9-dioxatricyclo[4.4.0.0²,⁴]decan-5-ol

(8s,10s)-2-(hydroxymethyl)-8,10-dimethoxy-3,9-dioxatricyclo[4.4.0.0²,⁴]decan-5-ol

C11H18O6 (246.1103)